{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:36:14Z","timestamp":1767864974139,"version":"3.49.0"},"reference-count":139,"publisher":"Elsevier","isbn-type":[{"value":"9780443219337","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA033930"],"award-info":[{"award-number":["R01 DA033930"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA055825"],"award-info":[{"award-number":["R01 DA055825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009238","name":"Virginia Commonwealth University","doi-asserted-by":"publisher","award":["AP00001507"],"award-info":[{"award-number":["AP00001507"]}],"id":[{"id":"10.13039\/100009238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.apha.2023.09.001","type":"book-chapter","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T15:45:11Z","timestamp":1697816711000},"page":"83-124","source":"Crossref","is-referenced-by-count":2,"title":["Structural and functional perspectives on interactions between synthetic cathinones and monoamine transporters"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apha.2023.09.001_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/7854_2016_54","article-title":"Predicting the abuse liability of entactogen-class, new and emerging psychoactive substances via preclinical models of drug self-administration","volume":"32","author":"Aarde","year":"2017","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"21","key":"10.1016\/bs.apha.2023.09.001_bib2","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1021\/ja017687n","article-title":"New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: Synthesis and biological applications","volume":"124","author":"Adams","year":"2002","journal-title":"Journal of the American Chemical Society"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib3","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1016\/S0006-3495(02)75328-9","article-title":"Flux coupling in the human serotonin transporter","volume":"83","author":"Adams","year":"2002","journal-title":"Biophysical Journal"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib4","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0006-3495(03)74587-1","article-title":"Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis","volume":"85","author":"Adams","year":"2003","journal-title":"Biophysical Journal"},{"issue":"7","key":"10.1016\/bs.apha.2023.09.001_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072057","article-title":"Synthetic cathinones: Recent developments, enantioselectivity studies and enantioseparation methods","volume":"27","author":"Almeida","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/bs.apha.2023.09.001_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/acschemneuro.8b00138","article-title":"Effects of N-alkyl-4-methylamphetamine optical isomers on plasma membrane monoamine transporters and abuse-related behavior","volume":"9","author":"Battisti","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"issue":"5","key":"10.1016\/bs.apha.2023.09.001_bib7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2023.09.001_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/7854_2016_53","article-title":"Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs","volume":"32","author":"Baumann","year":"2017","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2023.09.001_bib10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","article-title":"Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project","volume":"53","author":"Beck","year":"2015","journal-title":"Clinical Toxicology (Phila)"},{"issue":"8","key":"10.1016\/bs.apha.2023.09.001_bib11","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1046\/j.1460-9568.2000.00155.x","article-title":"Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: Functional consequences","volume":"12","author":"Benoit-Marand","year":"2000","journal-title":"The European Journal of Neuroscience"},{"issue":"40","key":"10.1016\/bs.apha.2023.09.001_bib12","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1074\/jbc.M117.794081","article-title":"Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates","volume":"292","author":"Bhat","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/ml500113s","article-title":"Hybrid dopamine uptake blocker-serotonin releaser ligands: A new twist on transporter-focused therapeutics","volume":"5","author":"Blough","year":"2014","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"10","key":"10.1016\/bs.apha.2023.09.001_bib14","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/bph.13030","article-title":"Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues","volume":"172","author":"Bonano","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"37","key":"10.1016\/bs.apha.2023.09.001_bib15","doi-asserted-by":"crossref","first-page":"25764","DOI":"10.1074\/jbc.M114.574269","article-title":"The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride","volume":"289","author":"Borre","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib16","first-page":"257","article-title":"The rat norepinephrine transporter: molecular cloning from PC12 cells and functional expression","volume":"52","author":"Bruss","year":"1997","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00213-013-2967-2","article-title":"Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of \u201cbath salts,\u201d produce opposite effects at the human dopamine transporter","volume":"227","author":"Cameron","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/bs.apha.2023.09.001_bib18","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/bph.12061","article-title":"Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter","volume":"168","author":"Cameron","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2023.09.001_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ceca.2015.06.013","article-title":"Amphetamine activates calcium channels through dopamine transporter-mediated depolarization","volume":"58","author":"Cameron","year":"2015","journal-title":"Cell Calcium"},{"issue":"45","key":"10.1016\/bs.apha.2023.09.001_bib20","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.0403299101","article-title":"Dopamine transporters depolarize neurons by a channel mechanism","volume":"101","author":"Carvelli","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.09.001_bib21","first-page":"185","article-title":"Cloning and expression of the mouse serotonin transporter","volume":"43","author":"Chang","year":"1996","journal-title":"Brain"},{"issue":"7","key":"10.1016\/bs.apha.2023.09.001_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41594-019-0253-7","article-title":"Monoamine transporters: Structure, intrinsic dynamics and allosteric regulation","volume":"26","author":"Cheng","year":"2019","journal-title":"Nature Structural & Molecular Biology"},{"issue":"12","key":"10.1016\/bs.apha.2023.09.001_bib23","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s00213-019-05339-4","article-title":"Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinopentiophenone (alpha-PVP) in rhesus monkeys","volume":"236","author":"Collins","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.apha.2023.09.001_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39945","article-title":"Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement","volume":"7","author":"Corre","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","article-title":"Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines","volume":"381","author":"Cozzi","year":"1999","journal-title":"European Journal of Pharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.09.001_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2012.10.001","article-title":"Mexico\u2019s precursor chemical controls: emergence of less potent types of methamphetamine in the United States","volume":"129","author":"Cunningham","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/bs.apha.2023.09.001_bib27","first-page":"1762","article-title":"Investigation of the optical isomers of methcathinone, and two achiral analogs, at monoamine transporters and in intracranial self-stimulation studies in rats","volume":"11","author":"Davies","year":"2020","journal-title":"ACS\u00a0Chemical Neuroscience"},{"key":"10.1016\/bs.apha.2023.09.001_bib28","first-page":"2527","article-title":"Structure-activity relationships for a recently controlled synthetic cathinone dopamine transporter reuptake inhibitor: Alpha-Pyrrolidinohexiophenone (alpha-PHP)","volume":"14","author":"Davies","year":"2023","journal-title":"ACS\u00a0Chemical Neuroscience"},{"key":"10.1016\/bs.apha.2023.09.001_bib29","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8384.1","article-title":"A current view of serotonin transporters","volume":"5","author":"De Felice","year":"2016","journal-title":"F1000Res"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.09.001_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-2647(01)00137-X","article-title":"Single-file diffusion and neurotransmitter transporters: Hodgkin and Keynes model revisited","volume":"62","author":"DeFelice","year":"2001","journal-title":"Bio Systems"},{"issue":"14","key":"10.1016\/bs.apha.2023.09.001_bib31","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2023.09.001_bib32","unstructured":"EMCDDA. (2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (June 2022). Luxembourg: Publications Office of the European Union, doi:10.2810\/396103 ."},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1523\/JNEUROSCI.2796-07.2008","article-title":"Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function","volume":"28","author":"Erreger","year":"2008","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release","volume":"360","author":"Eshleman","year":"2017","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.09.001_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"16","key":"10.1016\/bs.apha.2023.09.001_bib36","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1073\/pnas.93.16.8671","article-title":"Norepinephrine transporters have channel modes of conduction","volume":"93","author":"Galli","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Pt 10","key":"10.1016\/bs.apha.2023.09.001_bib37","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1242\/jeb.198.10.2197","article-title":"Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants","volume":"198","author":"Galli","year":"1995","journal-title":"The Journal of Experimental Biology"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/FBP.0000000000000540","article-title":"Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats","volume":"31","author":"Gatch","year":"2020","journal-title":"Behavioural Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0026-895X(25)08925-4","article-title":"Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter","volume":"42","author":"Giros","year":"1992","journal-title":"Molecular Pharmacology"},{"issue":"6566","key":"10.1016\/bs.apha.2023.09.001_bib40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"issue":"32","key":"10.1016\/bs.apha.2023.09.001_bib41","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.15585\/mmwr.mm7132a3","article-title":"Notes from the field: Overdose deaths involving eutylone (psychoactive bath salts) - United States, 2020","volume":"71","author":"Gladden","year":"2022","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/bs.apha.2023.09.001_bib42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","article-title":"Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention","volume":"69","author":"Glennon","year":"2014","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/bs.apha.2023.09.001_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/7854_2016_41","article-title":"Structure-activity relationships of synthetic cathinones","volume":"32","author":"Glennon","year":"2017","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"Pt 1","key":"10.1016\/bs.apha.2023.09.001_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainresbull.2016.04.011","article-title":"Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinovalerophenone (alpha-PVP)","volume":"126","author":"Glennon","year":"2016","journal-title":"Brain Research Bulletin"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0091-3057(87)90164-X","article-title":"Methcathinone: A new and potent amphetamine-like agent","volume":"26","author":"Glennon","year":"1987","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"14","key":"10.1016\/bs.apha.2023.09.001_bib46","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1021\/ja00093a019","article-title":"Biosynthetic route to the ephedra alkaloids","volume":"116","author":"Gruesorensen","year":"1994","journal-title":"Journal of the American Chemical Society"},{"issue":"10","key":"10.1016\/bs.apha.2023.09.001_bib47","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","article-title":"Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence","volume":"269","author":"Gu","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S1461145713001132","article-title":"Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination","volume":"17","author":"Hysek","year":"2014","journal-title":"The International Journal of Neuropsychopharmacology\/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"Pt B(0 0)","key":"10.1016\/bs.apha.2023.09.001_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuropharm.2013.04.031","article-title":"Neurocircuitry of drug reward","volume":"76","author":"Ikemoto","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2023.09.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100787","article-title":"Optogenetically-induced multimerization of the dopamine transporter increases uptake and trafficking to the plasma membrane","volume":"296","author":"Ingram","year":"2021","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.apha.2023.09.001_bib51","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00213-019-05203-5","article-title":"Multi-modal antidepressant-like action of 6- and 7-chloro-2-aminodihydroquinazolines in the mouse tail suspension test","volume":"236","author":"Iyer","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib52","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jnc.15145","article-title":"SLC6 transporter oligomerization","volume":"157","author":"Jayaraman","year":"2021","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1016\/bs.apha.2023.09.001_bib53","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41386-018-0071-3","article-title":"Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats","volume":"43","author":"Johnson","year":"2018","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib55","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acschemneuro.2c00666","article-title":"Do 2-(Benzoyl)piperidines represent a novel class of hDAT reuptake inhibitors?","volume":"14","author":"Jones","year":"2023","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.apha.2023.09.001_bib56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","article-title":"The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals","volume":"57","author":"Kamilar-Britt","year":"2015","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"Pt A","key":"10.1016\/bs.apha.2023.09.001_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuropharm.2017.10.007","article-title":"MDPV and alpha-PVP use in humans: The twisted sisters","volume":"134","author":"Karila","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-011-2383-4","article-title":"A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"219","author":"Kirkpatrick","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib59","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00213-015-4186-5","article-title":"Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys","volume":"233","author":"Kohut","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"15","key":"10.1016\/bs.apha.2023.09.001_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158277","article-title":"The pharmacological profile of second generation pyrovalerone cathinones and related cathinone derivative","volume":"22","author":"Kolaczynska","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.apha.2023.09.001_bib61","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/acschemneuro.5b00006","article-title":"Stereoselective actions of methylenedioxypyrovalerone (MDPV) to inhibit dopamine and norepinephrine transporters and facilitate intracranial self-stimulation in rats","volume":"6","author":"Kolanos","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"issue":"10","key":"10.1016\/bs.apha.2023.09.001_bib62","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acschemneuro.5b00160","article-title":"Structural modification of the designer stimulant alpha-pyrrolidinovalerophenone (alpha-PVP) influences potency at dopamine transporters","volume":"6","author":"Kolanos","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"issue":"12","key":"10.1016\/bs.apha.2023.09.001_bib63","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/cn4001236","article-title":"\u201cDeconstruction\u201d of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter","volume":"4","author":"Kolanos","year":"2013","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib64","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acschemneuro.8b00525","article-title":"DARK classics in chemical neuroscience: Alpha-Pyrrolidinovalerophenone (\u201cFlakka\u201d)","volume":"10","author":"Kolesnikova","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib65","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib66","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2015.07.014","article-title":"Intact-brain analyses reveal distinct information carried by SNc dopamine subcircuits","volume":"162","author":"Lerner","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2004.10.006","article-title":"A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) with cocaine in rhesus monkeys","volume":"78","author":"Lile","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib68","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/S0006-3495(96)79506-1","article-title":"Single-channel currents produced by the serotonin transporter and analysis of a mutation affecting ion permeation","volume":"71","author":"Lin","year":"1996","journal-title":"Biophysical Journal"},{"issue":"5","key":"10.1016\/bs.apha.2023.09.001_bib69","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0091-3057(79)90040-6","article-title":"Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration","volume":"11","author":"Lyness","year":"1979","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.apha.2023.09.001_bib70","first-page":"1","article-title":"The growing problem of new psychoactive substances (NPS)","volume":"32","author":"Madras","year":"2017","journal-title":"Current Topics in Behavioral Neurosciences"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib71","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0896-6273(94)90337-9","article-title":"Conducting states of a mammalian serotonin transporter","volume":"12","author":"Mager","year":"1994","journal-title":"Neuron"},{"issue":"26","key":"10.1016\/bs.apha.2023.09.001_bib72","doi-asserted-by":"crossref","first-page":"13762","DOI":"10.1074\/jbc.M115.704049","article-title":"Fluorescence resonance energy transfer-based structural analysis of the dihydropyridine receptor alpha1S subunit reveals conformational differences induced by binding of the beta1a subunit","volume":"291","author":"Mahalingam","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/bs.apha.2023.09.001_bib73","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.2174\/092986712800099749","article-title":"Selective serotonin reuptake inhibitors (SSRIs): Therapeutic drug monitoring and pharmacological interactions","volume":"19","author":"Mandrioli","year":"2012","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2023.09.001_bib74","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"issue":"Pt A","key":"10.1016\/bs.apha.2023.09.001_bib75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2017.10.006","article-title":"Fluorinated phenmetrazine \u201clegal highs\u201d act as substrates for high-affinity monoamine transporters of the SLC6 family","volume":"134","author":"Mayer","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib76","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3565(24)38016-4","article-title":"l-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine","volume":"288","author":"Melega","year":"1999","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib77","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/jm050797a","article-title":"1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: A promising class of monoamine uptake inhibitors","volume":"49","author":"Meltzer","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib78","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clpt.2006.06.013","article-title":"Human pharmacology of the methamphetamine stereoisomers","volume":"80","author":"Mendelson","year":"2006","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib79","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcph.266","article-title":"How MDMA\u2019s pharmacology and pharmacokinetics drive desired effects and harms","volume":"54","author":"Michael White","year":"2014","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","article-title":"Death following recreational use of designer drug \u201cbath salts\u201d containing 3,4-methylenedioxypyrovalerone (MDPV)","volume":"8","author":"Murray","year":"2012","journal-title":"Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042226","article-title":"Neuropsychopharmacology of emerging drugs of abuse: Meta- and para-halogen-ring-substituted alpha-PVP (\u201cflakka\u201d) derivatives","volume":"23","author":"Nadal-Gratacos","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.apha.2023.09.001_bib82","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/acschemneuro.2c00772","article-title":"Structure-activity relationship of N-ethyl-hexedrone analogues: Role of the alpha-carbon side-chain length in the mechanism of action, cytotoxicity, and behavioral effects in mice","volume":"14","author":"Nadal-Gratacos","year":"2023","journal-title":"ACS Chemical Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib83","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.112.007419","article-title":"Intracranial self-stimulation to evaluate abuse potential of drugs","volume":"66","author":"Negus","year":"2014","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apha.2023.09.001_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.863088","article-title":"Entactogens: How the name for a novel class of psychoactive agents originated","volume":"13","author":"Nichols","year":"2022","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.apha.2023.09.001_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.021","article-title":"para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter","volume":"161","author":"Niello","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00212770","article-title":"Drug discrimination studies with MDMA and amphetamine","volume":"95","author":"Oberlender","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.apha.2023.09.001_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.forsciint.2016.01.037","article-title":"A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013-2015","volume":"265","author":"Odoardi","year":"2016","journal-title":"Forensic Science International"},{"issue":"5766","key":"10.1016\/bs.apha.2023.09.001_bib88","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bmj.3.5766.70","article-title":"Drugs of dependence though not of abuse: Fenfluramine and imipramine","volume":"3","author":"Oswald","year":"1971","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib89","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/00952990.2012.694535","article-title":"Intoxication delirium following use of synthetic cathinone derivatives","volume":"38","author":"Penders","year":"2012","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib90","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0896-6273(03)00605-6","article-title":"Regulating the conducting states of a mammalian serotonin transporter","volume":"40","author":"Quick","year":"2003","journal-title":"Neuron"},{"issue":"17","key":"10.1016\/bs.apha.2023.09.001_bib91","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.1074\/jbc.M110783200","article-title":"Serotonin transporter function and pharmacology are sensitive to expression level: Evidence for an endogenous regulatory factor","volume":"277","author":"Ramsey","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.09.001_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","article-title":"Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones","volume":"25","author":"Rickli","year":"2015","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2023.09.001_bib94","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amjmed.2012.02.019","article-title":"Psychoactive \u201cbath salts\u201d intoxication with methylenedioxypyrovalerone","volume":"125","author":"Ross","year":"2012","journal-title":"The American Journal of Medicine"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.09.001_bib95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/syn.890140106","article-title":"Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters","volume":"14","author":"Rothman","year":"1993","journal-title":"Synapse (New York, N. Y.)"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib98","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-K","article-title":"Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: A pharmacological strategy for treating stimulant abuse","volume":"35","author":"Rothman","year":"2000","journal-title":"Synapse (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib99","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.103.053975","article-title":"In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates","volume":"307","author":"Rothman","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.09.001_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115513","article-title":"Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca(2+) channels as sensors","volume":"419","author":"Ruchala","year":"2021","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ceca.2014.04.003","article-title":"Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels","volume":"56","author":"Ruchala","year":"2014","journal-title":"Cell Calcium"},{"issue":"7","key":"10.1016\/bs.apha.2023.09.001_bib102","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/S0021-9258(17)40535-7","article-title":"Active transport of 5-hydroxytryptamine by plasma membrane vesicles isolated from human blood platelets","volume":"252","author":"Rudnick","year":"1977","journal-title":"The Journal of Biological Chemistry"},{"issue":"22","key":"10.1016\/bs.apha.2023.09.001_bib103","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1021\/bi00615a021","article-title":"Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium","volume":"17","author":"Rudnick","year":"1978","journal-title":"Biochemistry"},{"issue":"34","key":"10.1016\/bs.apha.2023.09.001_bib104","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1021\/bi200405c","article-title":"Proteins interacting with monoamine transporters: Current state and future challenges","volume":"50","author":"Sager","year":"2011","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib105","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/npp.2014.325","article-title":"\u2018Second-generation\u2019 mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function","volume":"40","author":"Saha","year":"2015","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2023.09.001_bib106","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/bph.13043","article-title":"Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues","volume":"172","author":"Sakloth","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib107","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1074\/jbc.M111.304261","article-title":"Unifying concept of serotonin transporter-associated currents","volume":"287","author":"Schicker","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12842","article-title":"Stereoselective neurochemical, behavioral, and cardiovascular effects of alpha-pyrrolidinovalerophenone enantiomers in male rats","volume":"25","author":"Schindler","year":"2020","journal-title":"Addiction Biology"},{"issue":"5","key":"10.1016\/bs.apha.2023.09.001_bib109","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4000421","article-title":"Anti-hyperactivity medication: Methylphenidate and amphetamine","volume":"3","author":"Seeman","year":"1998","journal-title":"Molecular Psychiatry"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib110","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acschemneuro.7b00055","article-title":"Deconstructed analogues of bupropion reveal structural requirements for transporter inhibition versus substrate-induced neurotransmitter release","volume":"8","author":"Shalabi","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib111","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1523\/JNEUROSCI.2604-17.2017","article-title":"Amphetamine reverses escalated cocaine intake via restoration of dopamine transporter conformation","volume":"38","author":"Siciliano","year":"2018","journal-title":"The Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib112","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"23","key":"10.1016\/bs.apha.2023.09.001_bib113","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2012.34423","article-title":"A trip on \u201cbath salts\u201d is cheaper than meth or cocaine but much more dangerous","volume":"308","author":"Slomski","year":"2012","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"10","key":"10.1016\/bs.apha.2023.09.001_bib114","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/npp.2017.98","article-title":"N-Alkylated analogs of 4-methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability","volume":"42","author":"Solis","year":"2017","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2023.09.001_bib115","first-page":"31385","article-title":"Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters","volume":"6","author":"Solis","year":"2016","journal-title":"Scientific\u00a0Reports"},{"issue":"12","key":"10.1016\/bs.apha.2023.09.001_bib116","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1074\/jbc.M111.267757","article-title":"4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP+) is a fluorescent substrate for the human serotonin transporter","volume":"287","author":"Solis","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib117","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1523\/JNEUROSCI.17-03-00960.1997","article-title":"Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants","volume":"17","author":"Sonders","year":"1997","journal-title":"The Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib118","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clinical Toxicology (Phila)"},{"issue":"3","key":"10.1016\/bs.apha.2023.09.001_bib119","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00213-018-5103-5","article-title":"Using Ca(2+)-channel biosensors to profile amphetamines and cathinones at monoamine transporters: Electro-engineering cells to detect potential new psychoactive substances","volume":"236","author":"Steele","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.apha.2023.09.001_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108820","article-title":"Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV","volume":"200","author":"Steele","year":"2021","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.09.001_bib121","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0006-3495(96)79616-9","article-title":"A multi-substrate single-file model for ion-coupled transporters","volume":"70","author":"Su","year":"1996","journal-title":"Biophysical Journal"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib122","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: A review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib123","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.115.229559","article-title":"Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: Microdialysis studies of nucleus accumbens dopamine and serotonin","volume":"356","author":"Suyama","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2023.09.001_bib124","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrn1008","article-title":"Plasma membrane monoamine transporters: structure, regulation and function","volume":"4","author":"Torres","year":"2003","journal-title":"Nature Reviews. Neuroscience"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.09.001_bib126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0143-4160(85)90041-7","article-title":"Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths","volume":"6","author":"Tsien","year":"1985","journal-title":"Cell Calcium"},{"key":"10.1016\/bs.apha.2023.09.001_bib127","unstructured":"UNODC. (2019). World Drug Report 2019. 4. \u3008https:\/\/wdr.unodc.org\/wdr2019\/\u3009."},{"issue":"8","key":"10.1016\/bs.apha.2023.09.001_bib128","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ijnp\/pyab017","article-title":"Discriminative-stimulus effects of synthetic cathinones in squirrel monkeys","volume":"24","author":"Wakeford","year":"2021","journal-title":"The International Journal of Neuropsychopharmacology\/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"1","key":"10.1016\/bs.apha.2023.09.001_bib129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1021\/acschemneuro.8b00524","article-title":"Systematic structure-activity studies on selected 2-, 3-, and 4-monosubstituted synthetic methcathinone analogs as monoamine transporter releasing agents","volume":"10","author":"Walther","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.apha.2023.09.001_bib130","doi-asserted-by":"crossref","first-page":"1041277","DOI":"10.3389\/fpsyt.2022.1041277","article-title":"Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity","volume":"13","author":"Warner-Schmidt","year":"2022","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/bs.apha.2023.09.001_bib131","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1586\/ern.11.137","article-title":"An update on the pharmacotherapy of attention-deficit\/hyperactivity disorder in adults","volume":"11","author":"Wilens","year":"2011","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2023.09.001_bib132","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03033808","article-title":"Dopamine and reward: The anhedonia hypothesis 30 years on","volume":"14","author":"Wise","year":"2008","journal-title":"Neurotoxicity Research"},{"issue":"4156","key":"10.1016\/bs.apha.2023.09.001_bib133","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1126\/science.185.4156.1067","article-title":"Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey","volume":"185","author":"Woods","year":"1974","journal-title":"Science (New York, N. Y.)"},{"issue":"6","key":"10.1016\/bs.apha.2023.09.001_bib134","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/1556-4029.12260","article-title":"Deaths involving methylenedioxypyrovalerone (MDPV) in Upper East Tennessee","volume":"58","author":"Wright","year":"2013","journal-title":"Journal of Forensic Sciences"},{"issue":"9","key":"10.1016\/bs.apha.2023.09.001_bib135","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1021\/acschemneuro.9b00284","article-title":"Synthetic cathinone analogues structurally related to the central stimulant methylphenidate as dopamine reuptake inhibitors","volume":"10","author":"Yadav-Samudrala","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.apha.2023.09.001_bib136","series-title":"Methods of behavior analysis in neuroscience","article-title":"Drug discrimination","author":"Young","year":"2009"},{"issue":"15","key":"10.1016\/bs.apha.2023.09.001_bib137","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0024-3205(86)90337-1","article-title":"Fluoxetine-induced attenuation of amphetamine self-administration in rats","volume":"39","author":"Yu","year":"1986","journal-title":"Life Sciences"},{"issue":"12","key":"10.1016\/bs.apha.2023.09.001_bib138","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/S0968-0896(00)00210-8","article-title":"Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters","volume":"8","author":"Yu","year":"2000","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"Suppl 3","key":"10.1016\/bs.apha.2023.09.001_bib139","first-page":"191","article-title":"Safety of fluoxetine in the treatment of obesity","volume":"11","author":"Zerbe","year":"1987","journal-title":"International Journal of Obesity"}],"container-title":["Advances in Pharmacology","Pharmacological Advances in Central Nervous System Stimulants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:22:04Z","timestamp":1753356124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358923000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443219337"],"references-count":139,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2023.09.001","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}